Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-site, Open-label, Phase II, Randomized, Controlled Trial to Compare the Efficacy of RO7198457 Versus Watchful Waiting in Resected, Stage II (High Risk) and Stage III Colorectal Cancer Patients Who Are ctDNA Positive Following Resection

NCT04486378 is registered in ClinicalTrials.gov with BioNTech SE as lead sponsor.

NCT NCT04486378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04486378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-site, Open-label, Phase II, Randomized, Controlled Trial to Compare the Efficacy of RO7198457 Versus Watchful Waiting in Resected, Stage II (High Risk) and Stage III Colorectal Cancer Patients Who Are ctDNA Positive Following Resection
Lead sponsor
BioNTech SE
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 8, 2021
Completion date
November 30, 2026
Enrollment
327 (estimated)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer stage ii, colorectal cancer stage iii